Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries

Abstract Background Healthcare cannot achieve net-zero carbon without addressing operating theatres. The aim of this study was to prioritize feasible interventions to reduce the environmental impact of operating theatres. Methods This study adopted a four-phase Delphi consensus co-prioritization methodology. In phase 1, a systematic review of published interventions and global consultation of perioperative healthcare professionals were used to longlist interventions. In phase 2, iterative thematic analysis consolidated comparable interventions into a shortlist. In phase 3, the shortlist was co-prioritized based on patient and clinician views on acceptability, feasibility, and safety. In phase 4, ranked lists of interventions were presented by their relevance to high-income countries and low–middle-income countries. Results In phase 1, 43 interventions were identified, which had low uptake in practice according to 3042 professionals globally. In phase 2, a shortlist of 15 intervention domains was generated. In phase 3, interventions were deemed acceptable for more than 90 per cent of patients except for reducing general anaesthesia (84 per cent) and re-sterilization of ‘single-use’ consumables (86 per cent). In phase 4, the top three shortlisted interventions for high-income countries were: introducing recycling; reducing use of anaesthetic gases; and appropriate clinical waste processing. In phase 4, the top three shortlisted interventions for low–middle-income countries were: introducing reusable surgical devices; reducing use of consumables; and reducing the use of general anaesthesia. Conclusion This is a step toward environmentally sustainable operating environments with actionable interventions applicable to both high– and low–middle–income countries

Relación entre el dolor lumbar y los movimientos realizados en postura sedente prolongada. Revisión de la literatura

Resumen La evidencia científica muestra que existe una asociación entre dolor lumbar y postura sedente prolongada, además una de las poblaciones más sensibles es la de conductores con una alta prevalencia. Ahora bien los movimientos posturales en la silla son la respuesta natural del cuerpo debida a la incomodidad percibida por el dolor lumbar pero esta difiere en función de la historia previa. Con base en esto se realizó una revisión sobre los estudios que existen en relación al dolor lumbar y el movimiento en postura sedente prolongada, incluyendo la población de conductores, con el fin de comprender esta relación.  Se recuperaron 6226 artículos, de los cuales 16 artículos fueron publicados entre 1970 y 2011, estos proporcionaron la información necesaria para contestar la pregunta de revisión. Se pudo constatar que ninguno de los estudios han sido realizados en actividades de conducir y la mayoría se realizó con sujetos voluntarios sin considerar si la población era trabajadora. El movimiento con dolor lumbar en postura sedente prolongada solo se pudo explicar desde el rango de movimiento lumbar debido a que solo se encontró un artículo con estas características, hallando que los sintomáticos se mueven más pero que el dolor lumbar no disminuye en función del tiempo, es decir que conocemos muy poco acerca de la paradoja movimiento y dolor en postura sedente prolongada.Abstract Scientific evidence shows an association between low back pain and prolonged sitting posture, also one of the most sensitive populations to this disorder are the drivers with a high prevalence. Postural movements in the chair are body's natural response to perceived discomfort caused by back pain but this is different depending on each individual's background of back pain. Based on this, we perform a review of studies related to low back pain and movement in prolonged sitting posture, including the driver population, in order to understand this relationship. We retrieved 6226 articles, of which 16 matched the established criteria and provided the information necessary to answer the review question. We found that none of the studies considered were conducted in driving activities and most of them were done with volunteer subjects regardless if they were workers or not. The movement with low back pain in prolonged sitting posture could only be explained from the range of lumbar motion because only one article matched these characteristics, finding that symptomatic people move more but low back pain does not decrease as a function of time, proving that we know very little about the paradoxical between movement and pain in prolonged sitting posture.Correspondencia a: Maria Fernanda Maradei. Km 2 vía Bogotá, Condominio Hacienda San Miguel Casa 30 Piedecuesta, Santander, Colombia. Tel: 3002907502. [email protected]ón: Pontificia Universidad Javeriana, Universtiy of Texas.  No. de Proyecto: PPTA 416

Ultrasound Applied in the Reduction of Viscosity of Heavy Crude Oil

Reducing the viscosity of heavy oil through upgrading techniques is crucial to maintaining the demand for oil, which is growing at an annual rate of 1.8%. The phenomenon of acoustic cavitation occurs when ultrasound is applied in the treatment of heavy crudes. This is an emerging technology that is being developed to improve the physical and chemical properties of highly viscous crudes, which facilitates handling, increases the proportion of light factions, and improves their price in the market. Taking into account that it does not yet operate on an industrial scale, a bibliographic review of the advances in acoustic cavitation technology with ultrasound for the improvement of heavy crude is justified, to contribute to the development of its industrial application by identifying new approaches and research guidelines in engineering and science. The objective of this article is to show the advance of said technology and describe the experiments carried out by various authors. For this purpose, a literature review was conducted with documents published from 1970 to 2020, which were compiled through a systematic search in academic databases. As a result of this review, some conceptual gaps and deficiencies in the phenomenological foundation were found, which explain the current difficulties to implement experimental tests and design the process at larger scales. These deficiencies limit the quality and repeatability of the results. A need was also identified to focus the efforts on a systematic experimentation that fulfills the laboratory and pilot plant phases, which are essential to take these technologies to an industrial scale.La reducción de la viscosidad del crudo pesado mediante técnicas de mejoramiento es crucial para mantener la demanda de petróleo, que crece a una tasa anual de 1.8 %. El fenómeno de la cavitación acústica ocurre cuando el ultrasonido es aplicado en el tratamiento de crudos pesados. Esta es una tecnología emergente que se está desarrollando para mejorar las propiedades físicas y químicas de crudos altamente viscosos, lo cual facilita el manejo, aumenta la proporción de facciones livianas y mejora su precio en el mercado. Teniendo en cuenta que aún no opera a escala industrial, se justifica una revisión de literatura de los avances de la tecnología de cavitación acústica con ultrasonido para mejoramiento de crudo pesado, con el fin de contribuir con el desarrollo de su aplicación industrial mediante la identificación de nuevos enfoques y lineamientos de investigación en ingeniería y ciencias. El objetivo de este artículo es mostrar el avance de la tecnología y describir los experimentos realizados por diversos autores. Para ello, se realizó una revisión bibliográfica de los documentos que han sido publicados desde 1970 hasta 2020, dichos documentos se recopilaron mediante una búsqueda sistemática en bases de datos académicas. Como resultado de esta revisión, se encontraron algunos vacíos conceptuales y carencias en fundamentación fenomenológica, que explican las dificultades actuales para implementar tests experimentales y diseñar el proceso a escalas mayores. Estas carencias limitan la calidad y repetitividad en los resultados. También se identificó la necesidad de concentrar los esfuerzos en experimentación sistemática que cumpla con las fases de laboratorio y planta piloto, aspectos esenciales para llevar estas tecnologías a escala industrial

Characterisation of microbial attack on archaeological bone

As part of an EU funded project to investigate the factors influencing bone preservation in the archaeological record, more than 250 bones from 41 archaeological sites in five countries spanning four climatic regions were studied for diagenetic alteration. Sites were selected to cover a range of environmental conditions and archaeological contexts. Microscopic and physical (mercury intrusion porosimetry) analyses of these bones revealed that the majority (68%) had suffered microbial attack. Furthermore, significant differences were found between animal and human bone in both the state of preservation and the type of microbial attack present. These differences in preservation might result from differences in early taphonomy of the bones. © 2003 Elsevier Science Ltd. All rights reserved

Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry

International audienceIn this article, the name of the GLORIA-AF investigator Anastasios Kollias was given incorrectly as Athanasios Kollias in the Acknowledgements. The original article has been corrected

Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry

Background: Previous studies suggested potential ethnic differences in the management and outcomes of atrial fibrillation (AF). We aim to analyse oral anticoagulant (OAC) prescription, discontinuation, and risk of adverse outcomes in Asian patients with AF, using data from a global prospective cohort study. Methods: From the GLORIA-AF Registry Phase II-III (November 2011-December 2014 for Phase II, and January 2014-December 2016 for Phase III), we analysed patients according to their self-reported ethnicity (Asian vs. non-Asian), as well as according to Asian subgroups (Chinese, Japanese, Korean and other Asian). Logistic regression was used to analyse OAC prescription, while the risk of OAC discontinuation and adverse outcomes were analysed through Cox-regression model. Our primary outcome was the composite of all-cause death and major adverse cardiovascular events (MACE). The original studies were registered with ClinicalTrials.gov, NCT01468701, NCT01671007, and NCT01937377. Findings: 34,421 patients were included (70.0 ± 10.5 years, 45.1% females, 6900 (20.0%) Asian: 3829 (55.5%) Chinese, 814 (11.8%) Japanese, 1964 (28.5%) Korean and 293 (4.2%) other Asian). Most of the Asian patients were recruited in Asia (n = 6701, 97.1%), while non-Asian patients were mainly recruited in Europe (n = 15,449, 56.1%) and North America (n = 8378, 30.4%). Compared to non-Asian individuals, prescription of OAC and non-vitamin K antagonist oral anticoagulant (NOAC) was lower in Asian patients (Odds Ratio [OR] and 95% Confidence Intervals (CI): 0.23 [0.22-0.25] and 0.66 [0.61-0.71], respectively), but higher in the Japanese subgroup. Asian ethnicity was also associated with higher risk of OAC discontinuation (Hazard Ratio [HR] and [95% CI]: 1.79 [1.67-1.92]), and lower risk of the primary composite outcome (HR [95% CI]: 0.86 [0.76-0.96]). Among the exploratory secondary outcomes, Asian ethnicity was associated with higher risks of thromboembolism and intracranial haemorrhage, and lower risk of major bleeding. Interpretation: Our results showed that Asian patients with AF showed suboptimal thromboembolic risk management and a specific risk profile of adverse outcomes; these differences may also reflect differences in country-specific factors. Ensuring integrated and appropriate treatment of these patients is crucial to improve their prognosis. Funding: The GLORIA-AF Registry was funded by Boehringer Ingelheim GmbH

Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study

To provide a global, up-to-date picture of the prevalence, treatment, and outcomes of Candida bloodstream infections in intensive care unit patients and compare Candida with bacterial bloodstream infection. DESIGN: A retrospective analysis of the Extended Prevalence of Infection in the ICU Study (EPIC II). Demographic, physiological, infection-related and therapeutic data were collected. Patients were grouped as having Candida, Gram-positive, Gram-negative, and combined Candida/bacterial bloodstream infection. Outcome data were assessed at intensive care unit and hospital discharge. SETTING: EPIC II included 1265 intensive care units in 76 countries. PATIENTS: Patients in participating intensive care units on study day. INTERVENTIONS: None. MEASUREMENT AND MAIN RESULTS: Of the 14,414 patients in EPIC II, 99 patients had Candida bloodstream infections for a prevalence of 6.9 per 1000 patients. Sixty-one patients had candidemia alone and 38 patients had combined bloodstream infections. Candida albicans (n = 70) was the predominant species. Primary therapy included monotherapy with fluconazole (n = 39), caspofungin (n = 16), and a polyene-based product (n = 12). Combination therapy was infrequently used (n = 10). Compared with patients with Gram-positive (n = 420) and Gram-negative (n = 264) bloodstream infections, patients with candidemia were more likely to have solid tumors (p < .05) and appeared to have been in an intensive care unit longer (14 days [range, 5-25 days], 8 days [range, 3-20 days], and 10 days [range, 2-23 days], respectively), but this difference was not statistically significant. Severity of illness and organ dysfunction scores were similar between groups. Patients with Candida bloodstream infections, compared with patients with Gram-positive and Gram-negative bloodstream infections, had the greatest crude intensive care unit mortality rates (42.6%, 25.3%, and 29.1%, respectively) and longer intensive care unit lengths of stay (median [interquartile range]) (33 days [18-44], 20 days [9-43], and 21 days [8-46], respectively); however, these differences were not statistically significant. CONCLUSION: Candidemia remains a significant problem in intensive care units patients. In the EPIC II population, Candida albicans was the most common organism and fluconazole remained the predominant antifungal agent used. Candida bloodstream infections are associated with high intensive care unit and hospital mortality rates and resource use

Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies

Background: Geoeconomic variations in epidemiology, the practice of ventilation, and outcome in invasively ventilated intensive care unit (ICU) patients without acute respiratory distress syndrome (ARDS) remain unexplored. In this analysis we aim to address these gaps using individual patient data of four large observational studies. Methods: In this pooled analysis we harmonised individual patient data from the ERICC, LUNG SAFE, PRoVENT, and PRoVENT-iMiC prospective observational studies, which were conducted from June, 2011, to December, 2018, in 534 ICUs in 54 countries. We used the 2016 World Bank classification to define two geoeconomic regions: middle-income countries (MICs) and high-income countries (HICs). ARDS was defined according to the Berlin criteria. Descriptive statistics were used to compare patients in MICs versus HICs. The primary outcome was the use of low tidal volume ventilation (LTVV) for the first 3 days of mechanical ventilation. Secondary outcomes were key ventilation parameters (tidal volume size, positive end-expiratory pressure, fraction of inspired oxygen, peak pressure, plateau pressure, driving pressure, and respiratory rate), patient characteristics, the risk for and actual development of acute respiratory distress syndrome after the first day of ventilation, duration of ventilation, ICU length of stay, and ICU mortality. Findings: Of the 7608 patients included in the original studies, this analysis included 3852 patients without ARDS, of whom 2345 were from MICs and 1507 were from HICs. Patients in MICs were younger, shorter and with a slightly lower body-mass index, more often had diabetes and active cancer, but less often chronic obstructive pulmonary disease and heart failure than patients from HICs. Sequential organ failure assessment scores were similar in MICs and HICs. Use of LTVV in MICs and HICs was comparable (42·4% vs 44·2%; absolute difference -1·69 [-9·58 to 6·11] p=0·67; data available in 3174 [82%] of 3852 patients). The median applied positive end expiratory pressure was lower in MICs than in HICs (5 [IQR 5-8] vs 6 [5-8] cm H2O; p=0·0011). ICU mortality was higher in MICs than in HICs (30·5% vs 19·9%; p=0·0004; adjusted effect 16·41% [95% CI 9·52-23·52]; p&lt;0·0001) and was inversely associated with gross domestic product (adjusted odds ratio for a US$10 000 increase per capita 0·80 [95% CI 0·75-0·86]; p&lt;0·0001). Interpretation: Despite similar disease severity and ventilation management, ICU mortality in patients without ARDS is higher in MICs than in HICs, with a strong association with country-level economic status